Paper33782898
Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.
Alam T and 3 others. Drug Deliv Transl Res, 2022. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. Papers, record 33782898. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33782898
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hypertension | Major topic |
| Myocardial Infarction | Major topic |
| Nanostructures | Major topic |
| Administration, Oral | |
| Animals | |
| Antioxidants | |
| Drug Carriers | |
| Isoproterenol | |
| Isradipine | |
| Lipids | |
| Particle Size | |
| Rats |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7945331 | In vitro antioxidant activity of calcium antagonists against LDL oxidation compared with alpha-tocopherol. | Biochem Biophys Res Commun | 1994 | https://conductscience.org/library/papers/7945331 | PubMed |
| 2 | 29235598 | The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers. | Nanoscale | 2018 | https://conductscience.org/library/papers/29235598 | PubMed |
| 3 | 16321796 | Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis. | Philos Trans R Soc Lond B Biol Sci | 2005 | https://conductscience.org/library/papers/16321796 | PubMed |
| 4 | 24641324 | Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: in vitro and in vivo evaluation. | Drug Dev Ind Pharm | 2015 | https://conductscience.org/library/papers/24641324 | PubMed |
| 5 | 28284054 | Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability. | Colloids Surf B Biointerfaces | 2017 | https://conductscience.org/library/papers/28284054 | PubMed |
| 6 | 16521536 | [Electron microscopy description of cardiomyocytes from the left ventricle of rat heart after apoptosis induction by isoproterenol]. | Izv Akad Nauk Ser Biol | 2006 | https://conductscience.org/library/papers/16521536 | PubMed |
| 7 | 17330072 | Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17330072 | PubMed |
| 8 | 23535345 | Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. | Int J Pharm | 2013 | https://conductscience.org/library/papers/23535345 | PubMed |
| 9 | 25138256 | Amorphous isradipine nanosuspension by the sonoprecipitation method. | Int J Pharm | 2014 | https://conductscience.org/library/papers/25138256 | PubMed |
| 10 | 30935913 | QbD guided early pharmaceutical development study: Production of lipid nanoparticles by high pressure homogenization for skin cancer treatment. | Int J Pharm | 2019 | https://conductscience.org/library/papers/30935913 | PubMed |
| 11 | 21515375 | The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease. | Neurobiol Dis | 2011 | https://conductscience.org/library/papers/21515375 | PubMed |
| 12 | 21640809 | Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. | Int J Pharm | 2011 | https://conductscience.org/library/papers/21640809 | PubMed |
| 13 | 29402457 | Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers. | Int J Biol Macromol | 2018 | https://conductscience.org/library/papers/29402457 | PubMed |
| 14 | 30076853 | Adaptation of Quality by Design-Based Development of Isradipine Nanostructured-Lipid Carrier and Its Evaluation for In Vitro Gut Permeation and In Vivo Solubilization Fate. | J Pharm Sci | 2018 | https://conductscience.org/library/papers/30076853 | PubMed |
| 15 | 36810 | Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. | Anal Biochem | 1979 | https://conductscience.org/library/papers/36810 | PubMed |
| 16 | 19406231 | Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. | Eur J Pharm Sci | 2009 | https://conductscience.org/library/papers/19406231 | PubMed |
| 17 | 24364934 | Optimizing SLN and NLC by 2(2) full factorial design: effect of homogenization technique. | Mater Sci Eng C Mater Biol Appl | 2012 | https://conductscience.org/library/papers/24364934 | PubMed |
| 18 | 30551388 | Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30551388 | PubMed |
| 19 | 1827026 | The place of isradipine in the treatment of hypertension. | Am J Hypertens | 1991 | https://conductscience.org/library/papers/1827026 | PubMed |
| 20 | 26829018 | Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study. | Artif Cells Nanomed Biotechnol | 2017 | https://conductscience.org/library/papers/26829018 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42579251 | Application of nanotherapy in cardiovascular diseases featuring novel pharmacological mechanisms and drug delivery strategies. | Discov Nano | 2026 | https://conductscience.org/library/papers/42579251 | PubMed |
| 41839827 | Nanoparticles-based phototherapy systems: molecular mechanisms and clinical applications. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41839827 | PubMed |
| 40978960 | Enhancing Drug Efficacy: A Review of Research Progress in Drug-Loaded Microspheres. | Cureus | 2025 | https://conductscience.org/library/papers/40978960 | PubMed |
| 36768536 | Neurogenic Hypertension, the Blood-Brain Barrier, and the Potential Role of Targeted Nanotherapeutics. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768536 | PubMed |
| 36507276 | mRNA therapy for myocardial infarction: A review of targets and delivery vehicles. | Front Bioeng Biotechnol | 2022 | https://conductscience.org/library/papers/36507276 | PubMed |
| 34845679 | In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours. | Drug Deliv Transl Res | 2023 | https://conductscience.org/library/papers/34845679 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33782898
GET https://conductscience.org/api/papers/v1/33782898/references?page=2